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DETERMINATION OF THE STRUCTURE OF 
PROTEINS: STUDIES ON RIBONUCLEASE* 
STANFORD MOORE AND WILLIAM H. STEIN 
The Rockefeller Institute for Medical Research, 
New York, New York 
THE most recent Harvey Lecture that dealt to a considerabledegree with the present subject, the chemical structure of pro­
teins, was delivered in 1935 by our former chief, the late Dr. 
Max Bergmann.1 At that time, as a result of the efforts of many 
investigators, Dr. Bergmann himself included, proteins had come 
to be recognized as large molecules built up of hundreds of amino 
acid residues of about eighteen varieties joined to one another by 
peptide bonds to form long peptide chains. The peptide bonds, 
formed by the elimination of a molecule of water between the 
amino group of one amino acid and the carboxyl group of the 
next, are separated by -CH:: groups that bear the side chains of 
the amino acids. The side chains in a protein may be aliphatic, 
aromatic, or heterocyclic; they may contain a hydroxyl, a sulfhydryl, 
or a thio-ether group; they may be neutral, basic, or acidic. It has 
been generally believed that it is primarily the difference in the 
nature and arrangement of these groups that determines the 
physical, the chemical, and the biological properties 0f each in­
dividual protein. 
There are two principal aspects of the structure of proteins to 
be considered: the chemical composition of the molecule, with 
which we are concerned in this discussion, and the physical struc­
ture, or orientation of the atoms in space, knowledge of which is 
also essential to a full understanding of proteins and enzymes and 
how they function. 
Although the questions posed by the chemical structure of pro­
teins were recognized for many decades, it has been only within 
the past ten years that the evolution of new techniques has made 
possible rapid progress toward the solution of some of these prob-
* Lecture delivered February 21, 1957
119 
120 STANFORD MOORE AND WILLIAM H. STEIN 
lems. Beginning with the introduction of the chromatographic 
method into protein chemistry by Martin and Synge, and aided 
by countercurrent distribution, as developed by Craig, and zone 
electrophoresis, as devised by Wieland, Durrum, and Tiselius and 
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FIG. 1. The structure of oxytocin from beef pituitary glands ( du Vigneaud and associates2 ). 
Kunkel, knowledge of peptides and proteins has been accumulat­
ing at an increasing rate. One important milestone is the synthesis 
of the peptide hormones vasopressin and oxytocin by du Vigneaud 
and his group, an accomplishment described in a Harvey Lecture 
two years ago.2 In Fig. 1 is shown the formula of bxytocin, a 
peptide containing 9 amino acid residues and possessing a molecu­
lar weight of 1007. The full chemic!'l-1 structure of the side chains 
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of the amino acids can be represented in the figure, as can the 
location of the disulfide bond that holds the peptide chain in the 
form of a ring. When much larger molecules are portrayed, the 
formulas of the amino acids usually need to be abbreviated, as is 
now customary, by the use of the first three letters of their names, 
in the manner indicated in the lower part of the figure. Du 
Vigneaud's research has many facets of interest, but of particular 
significance for the subject of this lecture is the fundamental sup­
port that it has furnished for the peptide theory. The structure of 
the hormone was deduced from degradative experiments, and a 
peptide possessing this structure was synthesized and found to 
exhibit full biological activity. 
Another classic achievement is the elucidation, by Sanger and 
his colleagues, 3•4 of the chemical structure of insulin, a protein of 
51 amino acid residues and a molecular weight of 5733. The 
formula, which has been derived through research carried out over 
the past ten years, is shown in Fig. 2 in abbreviated form. Insulin 
is the largest complex organic molecule for which a structural 
formula can be written. Sanger's brilliant achievement has been 
followed by several notable advances in other laboratQries. These 
include the working out of the structure of the adrenocorticotropic 
hormones (ACTH), which have 39 residues, by Bell and asso­
ciates,5 Li et aJ,.,6•7 and White and Landmann; 8 the determination 
of the structure of glucagon, which has 29 residues, by Behrens 
and colleagues;9 and the elucidation of the structure of the mela­
nocyte stimulating hormone, which has 18 residues, by Harris and 
Roos, 10 and Geschwind, Li, and Barnafi.11 Structural analysis of 
the more typical proteins having molecular weights in the range 
10,000 to 100,000 still lies ahead. Even this goal is in sight, how­
ever, and in order to illustrate how it may be approached, we 
should like to take you with us as far as we have gone toward 
unraveling the structure of one such protein of 124 amino acid 
residues, the enzyme ribonuclease. 
At the outset, it is a pleasure to emphasize the fact that this re­
search has been carried out jointly with Dr. C. H. W. Hirs. 
Through his extensive and skillful experimentation, he is directly 
responsible for a large part of the data on the structure of ribo­
nuclease presented in this lecture. 
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Ribonuclease was first described in 1920 by Jones,12 who 
showed that there was present in beef pancreas a relatively heat­
stable enzyme, capable of digesting yeast nucleic acid. Dubos and 
Thompson13 partially purified the enzyme some eighteen years 
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FIG. 2. The structure of beef insulin ( Sanger and associates8 ' 4 ). The first three 
letters of the names of the amino acids are used as abbreviations. 
later, and in 1940, Kunitz14 described the isolation of bovine 
ribonuclease in crystalline form. It proved to be a relatively small 
molecule as proteins go, having a molecular weight of about 
14,000. The isoelectric point was shown to be near pH 8, and the 
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analyses of Brand15 revealed the presence of all of the usual amino
acids, with the significant exception of tryptophan. Recently the 
specificity of the enzyme has been studied in several laboratories, 
notably those of Todd, of Cohn, and of Markham,cus and it has 
been found to hydrolyze the large nucleic acid molecule at the 
phosphate bond of pyrimidine, but not of purine nucleotides 
(Fig. 3). For precise work it is preferable to use substrates of 
lower molecular weight than RN A and of known structure, and 
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FIG. 3. The enzymatic specificity of ribonuclease.16 The types of phosphate ester 
bonds of pyrimidine nucleotides cleaved by the enzyme are indicated by the 
dashed line. 
fortunately it has been found that ribonuclease hydrolyzes the ester 
phosphate bond in the simple synthetic pyrimidine nucleotides, 
2',3'-cyclic cytidylic and uridylic acids, as illustrated in Fig. 3. 
All of these properties of ribonuclease rendered it a favorable 
protein for structural analysis. Since such research is not possible 
unless there is available a highly purified preparation of the pro­
tein with which to work, it is fortunate that ribonuclease has been 
one of the first proteins the homogeneity of which has been 
studied by the improved chromatographic techniques devised in 
the last decade. Martin and Porter11 in England employed liquid-
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liquid chromatography for this purpose, and Dr. Hirs in our 
laboratory used columns of the polycarboxylic acid resin, IRC-50.18 
Both methods of chromatography were capable of removing de­
tectable amounts of impurity from crystalline ribonuclease. Evi­
dence was also obtained for the occurrence in pancreas of a small 
amount of a second protein possessing ribonuclease activity. The 
predominant enzyme, ribonuclease A, was prepared in chromato­
graphically homogeneous form, as can be seen in Fig. 4, and it is 
this purified preparation that furnished the starting material for 
10 20 
:Eff1uent volume, cc. 
Frn. 4. Chromatographic homogeneity of a sample of bovine ribonuclease A 
prepared by passage over IRC-50.18 Chromatography was performed with a 
0.9 X 30-cm. column of the polycarboxylic acid resin and with phosphate buffer 
at pH 6.47 as the eluent. 
the next step in the structural analysis, namely, the determination 
of the amino acid composition.19 This was done by chromato­
graphing the hydrolyzate from 2 mg.-samples of ribonuclease A 
on buffered columns of the sulfonated polystyrene resin, Dowex 
50-X4,20 as is illustrated by the effluent curve shown· in Fig. 5.
In this curve, and in others somewhat like it that will be discussed
later, the horizontal axis gives the volume of eluent that has passed
through the column. The vertical axis gives the concentration of
amino acid in each small fraction of the effluent from the column,
as determined by a photometric ninhydrin method.21 The area of
each peak on the curve is proportional to the quantity of amino
acid in the original mixture.
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The results of this chromatographic analysis were, in general, 
in good agreement with the earlier findings of Brand, except for 
the values for alanine and leucine. Assuming a molecular weight 
of about 14,000, integral molar ratios were obtained for most of 
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FIG. 5. Chromatographic determination of the amino acid composition of an 
acid hydrolyzate of 2 mg. of ribonuclease A.19 The analysis was performed with 
a 0.9 X 150-cm. column of Dowex 50-X4 and eluents of the indicated pH and 
molarity. 
the amino acids. The analytical results have had to be revised 
slightly in the light of subsequent structural work, 22 which has 
indicated that the original estimates for the decomposition during 
hydrolysis of aspartic acid and of praline led to values that were 
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high by one residue each. The empirical formula for ribonuclease 
in terms of amino acid residues ( rather than the elements C, H, 
and N) is given in Table 1. Such a formula is useful as a first 
step in the determination of the structure of a protein. Note that 
there are 14 residues of the basic amino acids, 4 arginines and 10 
TABLE 1 
AMINO Acm COMPOSITION OF RIBONUCLEASE* 
Amino Acid 
Aspartic acid 
Glutamic acid 
Glycine 
Alanine 
Valine 
Leucine 
Isoleucine 
Serine 
Threonine 
Half-cystine 
Methionine 
Praline 
Phenylalanine 
Tyrosine 
Histidine 
Lysine 
Arginine 
Amide NH3 
Total number of residues 
* Ribonuclease from beef pancreas.21, 22 
Number of Residues 
per Molecule 
(mol. wt. 13,683) 
15 
12 
3 
12 
9 
2 
3 
15 
10 
8 
4 
4 
3 
6 
4 
10 
4 
(17) 
124 
lysines; that there are 8 half-cystine residues; and that several of 
the amino acids-glycine, phenylalanine, leucine, and isoleucine, 
for example-are present to the extent of only 2 to 4 residues per 
molecule. The total number of amino acid residues is 124, which, 
with 1 7 amide groups, and assuming the 124 residues to be pres­
ent in one peptide chain, leads to a calculated minimal molecular 
weight of 13,683. 
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The fact that ribonuclease does contain but a single peptide 
chain was shown by Dr. C. B. Anfinsen and his colleagues at the 
National Heart Institute in Bethesda. By the use of the dinitro­
phenyl technique of Sanger they succeeded in demonstrating that 
the first four residues of this single chain had the sequence 
Lys.Glu.Thr.Ala.-, starting at the amino-terminal end.23 In­
cluded in this lecture are frequent references to the work of Dr. 
Anfinsen and his group, for his laboratory and our own have both 
been working on the structure of ribonuclease, although our ap­
proaches have been somewhat different. It is a pleasure to ac­
knowledge the helpful interchange of information that has oc­
curred throughout the course of these investigations. 
Since ribonuclease does not appear to contain any sulfhydryl 
groups, the single peptide chain must be held in a folded con­
figuration by four disulfide bonds that join the eight half-cystine 
residues. Following the general procedure utilized by Sanger in 
his studies on the structure of insulin, these four disulfide bonds 
were split by oxidation with peroxyformic acid. This procedure 
does not separate peptide chains, as it does with insulin, but the 
single folded chain of ribonuclease is opened up into a form more 
readily hydrolyzed by proteolytic enzymes. In addition, the inter­
pretation of the results of such proteolytic cleavage is easier if it 
is no longer possible for different parts of the peptide chain to 
be held together by the -S-S- bonds. Under properly chosen 
experimental conditions, 24 peroxyformic acid almost quantitatively 
converts the half-cystine residues to cysteic acid residues, and 
methionine residues to the sulfone, without affecting any of the 
other amino acids in ribonuclease. It is important to note that 
ribonuclease fortunately does not contain tryptophan, which would 
be oxidized by peroxyformic acid with the formation of a number 
of products. 
At this point we are ready to begin the determination of the 
sequence of the 124 amino acid residues in the chain of oxidized 
ribonuclease. This chain is too large to be studied as such; it must 
first be reduced to fragments of a more manageable size. In the 
work of Sanger and his colleagues on the sequence of the amino 
acids in the oxidized A and B chains of insulin, partial hydrolysis 
with HCI was the principal method used to split the long chains 
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into peptides small enough for study. The products of this hy­
drolysis were then separated by paper chromatography. As 
Sanger25 pointed out, however, it is doubtful whether hydrolysis 
with concentrated HCI, which splits the peptide chain in a more 
or less random manner, could be used effectively with larger 
molecules. The complex mixture of peptides which would result 
from the partial acid hydrolysis of a protein of the size of ribo­
nuclease would be extremely difficult to fractionate. Moreover, the 
deduction of a unique structure for the parent molecule becomes 
progressively more difficult as the number of small fragments in­
creases. It was decided, therefore, to use proteolytic enzymes 
which, because of their specificity, cleave a protein into a limited 
number of fragments. Enzymatic hydrolysis was used by Sanger 
and his colleagues for the elucidation of parts of the structure of 
insulin, and was subsequently employed by Bell and associates5 
and by Li and his group6• 7 in their work on the structure of 
ACTH. 
Of the readily available proteolytic enzymes, trypsin possesses 
the sharpest specificity, as was demonstrated in the classic studies 
of Bergmann, Fruton, and Hofmann°r .2s carried out with the aid 
of synthetic substrates. On the basis of its specificity, trypsin 
might be expected to hydrolyze oxidized ribonuclease at the pep­
tide bonds involving the carboxyl groups of the 10 lysine and 4 
arginine residues present in the molecule, to yield 14 or 15 frag­
ments. Whether or not free lysine would be cleaved from the 
amino-terminal position could not be foretold with assurance, nor 
could the probability of the occurrence of trypsin-resistant lysyl­
prolyl"bonds be predicted. 
When about 200 mg. of oxidized ribonuclease were hydrolyzed 
by trypsin and the products formed were separated by ion ex­
change chromatography on columns of Dowex 50-X2, the results 
shown in Fig. 6 were obtained. 22 Columns were used in these 
studies in preference to paper chromatography, because quantita­
tive data were desired, and because it was necessary to obtain 10-
mg. to 50-mg. quantities of the larger and more complicated 
peptides in order to permit further structural work to be done. 
As a first step in this structural work, quantitative amino acid 
analyses were performed by ion exchange chromatography on an 
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aliquot of the material in each peak. The results were particularly 
informative in deciding whether or not a single peptide had been 
obtained, for a reasonably well purified peptide should contain 
only a limited number of amino acids in quantities that give in­
tegral molar ratios. The amino acid composition of each peptide 
obtained in relatively pure form is shown in Fig. 6. The sequence 
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[G1u,Gly,5er2, Tnr] Ly5(�;100%) 
I 1
6 
�y.s,A5p-NH2 ,Ala,VaLJLY,5(�; TI¼) A'Jp.Arg (7D;90%) 
.} 15 
-7-
1 Nli3 (from · ff I I lwgent�
Iffluent 1iter,s 0.5 1.0 1.5 2.0 
I-0.2NplU1,35
°-1---Gradua11y inc.rea5ing pli and [No+]-
Ly.s. Glu.Tnr.Ala .Ala.Alo.Ly.s(� ;100%) 
r . J '» 0,sp-Nli2, Glu-Ntt2,Ala,Tnr2 0 
{} I Ly,s (lQQ;l00 /o)
1£i.5p-NH2,Leu,Tnr]Ly.s(@; 951/o)�lu-NH2,Ph�Arg (75;55%)
1 1 5er.Arg(�;55fo) IJJ 
1 2 JJ+H: I" I 
2.5 30 3.5 4.0 4.5 
--(0.2 N pli.3.1-- 2.0N pli 5.1), 35
° tnroughout-------1
FrG. 6. Separation of the peptides present in a 20-hour tryptic hydrolyzate of 
200 mg. of oxidized ribonuclease.22 A 2 X 150-cm. column of Dowex 50-X2 
was employed. An additional peptide (No. 16) was eluted after a change at 
4.5 liters to 2 N sodium acetate buffer at pH 6.6. The abbreviation Cys repre­
sents a cysteic acid residue in the peptides from the oxidized protein. 
of the residues in the brackets is not known. The numbers in 
parenthesis give the yield of each peptide obtained after 3 and 
after 20 hours of tryptic hydrolysis. On the basic of the specificity 
of trypsin, the basic amino acid, lysine or arginine, is assigned to 
the carboxyl-terminal position. It will be noted that peptide No. 
10 contains two lysine residues. Inasmuch as DNP end-group 
analyses of this peptide placed one lysine at the amino-terminal 
position, it seems extremely probable that this fragment represents 
the amino-terminal sequence. Since the first four amino acids of 
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this sequence were shown by Anfinsen et al.23 to be Lys.Glu.Thr.­
Ala-, the finding of two more alanine residues and a lysine 
makes it possible to extend this sequence to seven amino acids. 
The amino acid analyses indicated that mixtures of peptides 
were present in the zones marked 2, 3, 4, and 13+14, and 
upon rechromatography under slightly different conditions, four 
additional purified peptides were obtained. Three of them were 
large, containing 19, 21, and 22 residues. Another peptide, No. 
16, not shown in Fig. 6, was obtained at the end of the chromato­
gram when the eluent was changed to a 2 N sodium acetate buffer 
of pH 6.6. This peptide was also large, containing 20 amino acid 
residues. It was devoid of lysine or arginine, however, and there­
fore must have been derived from the carboxyl-terminal portion 
of the chain. 
It should be emphasized that the procedures that. have been 
referred to are quantitative. The amino acid analyses help to in­
dicate whether or not the peptides are pure, in the sense of 
whether integral molar ratios for the constituents are obtained, 
and if they are impure, the analyses may show the extent of the 
contamination. Illustrative data are given in Table 2. In the 
majority of cases, as can be seen from the table, only 5 to 10 per 
cent or less of impurities were present, and the amino acid residues 
that make up the peptide stand out clearly. From these data, the 
yields given in Fig. 6 could be calculated, assuming each peptide 
to occur only once in the parent protein. 
As a result of the action of trypsin, thirteen peptides have been 
obtained in yields of 50 to 100 per cent, and these account for all 
of the 124 amino acid residues in oxidized ribonuclease. The com­
positions of these peptides, and the high yields in which they were 
isolated, indicate that transpeptidation by the enzyme is not occur­
ring, and that such rearrangements will not complicate the inter­
pretation of the results. 
Clearly, the next step is to determine the order in which these 
thirteen peptides are linked together, and for this purpose, it is 
necessary to study the nature of the products formed when oxi­
dized ribonuclease is cleaved at other sites by enzymes possessing 
different specificities. To effect this cleavage, chymotrypsin and 
pepsin have been used. 
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Chymotrypsin does not possess as attractively high a degree of 
specifi.y as does trypsin. A number of types of bond are split 
at measurable rates, but there is a considerable preference for link­
ages involving the carboxyl groups of phenylalanine, tyrosine, 
TABLE 2 
AMINO ACID COMPOSITION OF PEPTIDE FRACTIONS OBTAINED 
FROM TRYPTIC HYDROLYSIS OF OXIDIZED R!BONUCLEASE22 
Peptide 
O-Tryp O-Tryp O-Tryp O-Tryp O-Tryp
Amino Acid 2 4 5 6 7
Aspartic acid 3.06 3.15 1.10 0.14 1.06 
Glutamic acid 2.10 2.07 0.09 0.95 
Glycine 0.99 0.03 0.03 1.00 
Alanine 0.02 2.09 1.01 
Valine 0.95 0.07 
Leucine 0.01 0.04 0.06 0.07 
Isoleucine 0.95 0.08 0.08 0.03 0.03 
Serine 2.84 6.31 0.24 2.23 0.17 
Threonine 2.85 0.96 0.11 0.91 0.05 
Cysteic acid 2.01 1.13 1.00 0.06 
Methionine sulfone 0.95 2.98 0.04 0.04 
Proline 
Phenylalanine 0.03 
Tyrosine 1.97 0.96 
Histidine 1.14 
Lysine 0.06 0.99 0.95 1.05 0.07 
Arginine 0.97 0.07 0.06 0.94 
Ammonia (amide) (4.2) (3.3) (1.2) -0.1 0.0 
Total number of 
residues* 19 21 5 6 2 
* Totals of boldface figures given in round numbers. 
methionine ( and methionine sulfone), and leucine. As might be 
expected, therefore, and as is evident from Fig. 7, the peptide 
mixture obtained after 24 hours of hydrolysis by chymotrypsin21 
is more complex than that obtained with trypsin. The yields are 
also usually lower. Amino acid analyses indicated the presence of 
mixtures of peptides in the regions of the curve marked 4+5, 
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11 + 12, and 14+ 15 + 16. These were separated by rechromatog­
raphy under different conditions of pH and temperature, as was 
done before. A total of eighteen purified peptides, containing 
from 3 to 27 amino residues each, were isolated from the chymo­
tryptic hydrolyzate in yields of from 6 to 80 per cent. And finally, 
additional although less complete data were secured through the 
use of a third enzyme, pepsin. 28 
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F1G. 7. Separation of the peptides in a 24-hour chymotryptic hydrolyzate of 
oxidized ribonuclease.27 
In all, the amino acid compositions of forty or more peptides 
formed by the action of trypsin, chymotrypsin, and pepsin on oxi­
dized ribonuclease have been established. What this very consider­
able body of data can tell us about the structure of the molecule is 
shown in Fig. 8. Here is given a partial structural formula for 
oxidized ribonuclease that shows how the thirteen segments ob­
tained by tryptic hydrolysis are linked together. 
In Fig. 8 the chain has been divided into segments, which 
should be imagined as being joined end to end. The residues en­
closed within the parentheses in this formula are of undetermined 
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sequence. The probable location of the amide groups in glutamine 
and asparagine residues is indicated by the -NH2 symbol, al­
though this part of the scheme is the least certain. The peptides 
formed by trypsin are labeled O-Tryp with a number correspond­
ing to the numbering in Fig. 6, and are indicated by a solid line. 
The 0- means they have been derived from oxidized ribonuclease. 
Similarly, the chymotrypsin-peptides are indicated by the dashed 
line, and the pepsin-peptides by the dotted line. 
In deriving this scheme, three assumptions have been made. 
These are: ( 1 ) That the amino acid residues are linked to one 
another only through simple peptide bonds joining a-NH2 and 
a-COOH groups-that is, that the chain is unbranched. No evi­
dence that branching occurs has yet been found. ( 2) That in pep­
tides formed by the action of trypsin, an arginine or lysine residue,
if one is present, occupies the carboxyl-terminal position. And
( 3) that in peptides formed by the action of chymotrypsin, a tyro­
sine or phenylalanine residue, if one is present, occupies the car­
boxyl-terminal position. With these assumptions, the formula is
completely self-consistent and accommodates all of the data that
have been secured. Every peptide obtained fits-none have been
omitted. Finally, the scheme appears to be unique. No matter !).ow
we try, we cannot find another that will encompass all of the data.
The picture thus derived is also in accord with independent in­
formation acquired by Redfield and Anfinsen. 30 
Let us go very briefly into the type of reasoning that has lecl to 
this formulation.27 Actually, one can start at any point and arrive 
at the same picture, but it is most convenient to begin at the amino 
end of the chain. It has already been shown that O-Tryp 10, with 
its amino-terminal lysine, occupies the amino-terminal position in 
the molecule. A key peptide found in both the chymotrypsin and 
pepsin series of peptides is O-Chy 2 5. It has the same amino acid 
composition as O-Tryp 10 with one Phe residue added. This Phe 
is undoubtedly on the carboxyl end, which satisfies the specificity 
requirements of both chymotrypsin and pepsin. It follows, there­
fore, that the next peptide in the trypsin series that comes after 
O-Tryp 10 must have amino-terminal Phe. There are only three
possibilities, because there are only three Phe residues in ribo­
nuclease, and they are found in O-Tryp 9, 15, and 16. Peptide 16
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is excluded because, as we have seen, it is devoid of basic amino 
acids and comes from the carboxyl end of the chain. O-Tryp 9 can 
be eliminated because it was found, by the DNP technique, not to 
contain amino-terminal Phe. This, by elimination, leaves O-Tryp 
15 as the peptide following O-Tryp 10. Since O-Tryp 15 is a 
tripeptide, and Phe is at one end and Arg at the other, its structure 
is established and our accounting from the amino end has been 
increased to ten residues. 
We now turn back to the chymotrypsin series of peptides. The 
placing of O-T ryp 15 requires the next chymotrypsin peptide to 
begin with the sequence Glu-Arg-. There are only four O-Chy 
peptides that contain glutamic acid and arginine, namely, O-Chy 
14, 21, 22, and 27. O-Chy 14 and O-Chy 27 can be eliminated 
because if they were placed in this position, their amino acid com­
position would make it impossible for any remaining peptide of 
the trypsin series to follow O-Tryp 15. This leaves only O-Chy 
21 and 22, which have so similar and unique an amino acid com­
position-each contains much Ser, one Met, and one His-that it 
can be decided that they come from the same part of the molecule. 
The two are placed in the manner indicated in Fig. 8. This 
uniquely defines the beginning of the trypsin peptide that follows 
O-Tryp 15. O-Tryp 4 is the only one that contains Met, His, and 
six serines and hence must be the next segment in the chain. 
Without further pursuing this crossword puzzle type of occupa­
tion here, it can be stated that by alternating between the peptides 
of the trypsin and the chymotrypsin series, and occasionally calling 
on the pepsin experiments when necessary, it is possible to assem­
ble the complete scheme shown in Fig. 8. 
What amounts to almost clinching evidence in favor of this 
structure has come from experiments in which the larger trypsin 
FIG. 8. A partial structural formula for oxidized ribonuclease.27 The amino 
acids are considered to be arranged in a single chain with the segments in the 
figure joined end to end. The formula is based upon the study of the peptides 
liberated by tryptic, chymotryptic, and peptic hydrolysis of the oxidized protein. 
The tentative allocation of amide groups (-NH2) has been based upon the 
most recent results, which have permitted definite placement of some of the 
asparaginyl and glutaminyl residues.29 The residues in parentheses are of unde­
termined sequence. 
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peptides, Nos. 4, 9, 2, and 16, have been isolated and then hydro­
lyzed with chymotrypsin. In each case, peptides of the expected 
amino acid composition have been isolated from the hydrolyzate. 
This partial structural formula of ribonuclease serves several 
useful purposes. In the first place, although it is only a partial 
formula, it still reveals much about the way the enzyme is put 
together. None of the unknown sequences are longer than eight 
amino acid residues, and many are shorter. In the second place, the 
formula serves as a guide for further work. It permits three more 
or less independent investigations connected with the detailed 
structure of the enzyme to proceed simultaneously. These are: the 
determination of the complete sequence of the amino acid residues 
in the oxidized protein; the determination of the positions of the 
four disulfide bonds in the native protein, or in other words, find­
ing out which pairs of half-cystine resid
1:1
es were linked together 
before oxidation split them apart; and finally, the study of whether 
any particular portion of the entire large molecule is responsible 
for its enzymatic activity-briefly that is, whether ribonuclease has 
a so-called "active center," and if it does, where this "active 
center" is located. Let us take up these questions in order. 
Because the manner is already known in which the forty or 
more peptides formed by enzymatic hydrolysis are linked, detailed 
sequence studies of all of these peptides are not required. Only 
those are selected for sequence work that do not overlap one 
another and that are of a suitable size. The thirteen peptides of 
the trypsin series were the starting products. The nine smallest 
could be studied directly, but the four larger ones, 0-Tryp 4, 9, 2, 
and 16, were first hydrolyzed with chymotrypsin to give fourteen 
smaller fragments. 
In determining the sequence of amino acids in all of these pep­
tides, the phenylthiocarbamyl technique of Edman has been the 
principal procedure employed by Dr. Hirs. The reaction permits 
residues to be removed one at a time from the amino end of a 
peptide. The cleavage frequently is not quantitative, however, and 
carefully performed amino acid analyses at each stage of the deg­
radation are required to permit clear-cut interpretation of the 
results. 
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In addition to the Edman procedure, Dr. Hirs has been using 
two enzymatic methods of degradation. These employ carboxy­
peptidase, which splits amino acids from the carboxyl end of 
peptides, and leucine aminopeptidase, prepared according to 
Spackman, Smith, and Brown, 31 which acts in the same way at the 
opposite, or amino, end. By performing quantitative determina­
tions of the free amino acids released after varying periods of 
enzymatic action, the sequence of amino acids at either the car­
boxyl or amino end of the peptide may frequently be inf erred. 
Since the basic amino· acid residues are split off only with difficulty 
by carboxypeptidase, the hydrazinolysis method of Akabori and 
associates has been used to con.firm the presence of carboxyl­
terminal lysine. The enzymatic methods have the advantage that 
asparagine and glutamine residues are liberated as such, without 
hydrolysis of the sensitive {3- or y-amide bond. 
Sequence work of this kind is slow. Each peptide must be pre­
pared in adequate amounts, and its purity in terms of amino acid 
composition established before further work can proceed. Never­
theless, by a combination of techniques, Dr. Hirs has thus far 
established or confirmed the position of about half of the residues 
in oxidized ribonuclease. The results to date ( Hirs29 ) are shown 
in Fig. 9. The sequence of the first ten residues has been con­
firmed. The tetrapeptide sequence at O-Tryp 11, originally de­
termined by Redfield and Anfinsen30 has also been confirmed, and 
the order of the eight amino acids preceding it has been estab­
lished. Another sequence around the fourth and fifth half-cystine 
residues has been worked out, and near the carboxyl end of the 
chain a sequence of twenty-one amino acid residues has been de­
termined. The sequence of the four amino acids at the carboxyl 
end has been established by Anfinsen and associates. 23• 30 
While this sequence work has been proceeding, Dr. D. H. 
Spackman in our laboratory, and Drs. A. P. Ryle and C. B. An­
finsen have been attempting to determine which pairs of half­
cystine residues ( numbered 1 to 8 in Fig. 9) are connected by 
disulfide bonds. The problem is basically similar to the one al­
ready solved by Sanger and his colleagues in their work on insulin. 
Since ribonuclease in which the disulfide bonds are intact is not 
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hydrolyzed in simple aqueous solution by trypsin or chymotrypsin, 
Dr. Spackman has allowed enzymatic action to proceed in 2 M 
guanidinium chloride. 
The hydrolyzate obtained by tryptic plus chymotryptic cleavage 
of unoxidized ribonuclease was chromatographed on Dowex 
50-X2, and from two of the cystine-containing zones from the
chromatogram, two pairs of cysteic acid-containing peptides were
isolated.32 One pair was ( CyS03H, Asp--NH2 , Glu-NH2 , 
MetS02 ) and (CyS03H, Asp, Ileu, Thr, Ser, Arg), and the other
was (Asp-NH2, CySOaH, Ala, Val, L'ys) and (CyS03H,
Asp-NH2, Asp-NH2, Glu-NH2, Gly, Thr, Tyr). From the
Lys. Glu. Thr.Ala.Ala.Ala.Lys.Phe. Glu.Arg. (Asp, Glu, Thr,Sers,Met,His) .-
NH2 (i) NH2NH2 NH2 
I I I I I (Asp,Ala2,Ser3).Tyr.Cys.Asp.Glu.Met.Met.Lys.Ser.Arg.Asp.Leu.Thr.Lys.-
(2)I NH2 NH2 I I Asp.Arg.(Cys,Asp,Val,Pr0,Thr,Lys).Phe.(Glu,Val,Leu,Ser,His).-
INH2-I 1 r H2 �H2 � (Asp,Glu,Ala,Val).(Ser,Cys,Glu,Ala,Val).Lys.Asp.Val.Ala.Cys.Lys.-
NH2 NH2 NH2 (fill, NH2 I I I I Asp.Gly. (Asp, Glu, Thr,Cys) .Tyr.Glu.Ser.Tyr.Ser.Thr.Mec.-
@ NH2 
. ! I ( C ys,Asp,Ileu, Thr,Ser) .Arg. Glu.Ser. Thr .Ser. Gly .Lys. Tyr. Pro.Asp. -
(j)I NH2NH2 I I Ala. Cys. Tyr.Lys. Thr. Thr.Asp. Glu.Ala.Lys.His. (Val,Ileu2). -
� 1-NH27(Cys,Asp,Glu,Gly,Ala,Pro).Tyr.(Val2.Pro,His).Phe.Aso.Ala.Ser.Val 
FIG. 9. Arrangement of the amino acid residues in oxidized ribonuclease 
(Hirs) .29 The sequences determined to date are underlined. The residues in 
parenthesis are of undetermined order. The cysteic acid residues have been num­
bered consecutively, 1 to 8, starting from the amino end of the chain. 
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amino acid compositions of these peptides, without the per­
formance of any sequence studies, it could be concluded that one 
disulfide bond links half-cystine residues 1 and 6, and another 
unites residues 4 and 5. Ryle and Anfinsen, proceeding in a differ­
ent manner, have also obtained evidence in favor of a 4-5 
-S-S- bond. There are still two more to be located, and very
recently, Dr. Anfinsen has kindly informed us that they have
secured evidence33 indicating a linkage between half-cystines 2 and
8, and 3 and 7. As a result of these experiments, all four of the
2 
FIG. 10. A two-dimensional diagram indicating the positions of the four 
disulfide bonds in native ribonuclease (based upon the results of Spackman 
et al.32 and Ryle and Anfinsen33 ). 
disulfide bonds would appear to be accounted for, and from their 
arrangement, it is clear that the peptide chain in ribonuclease is 
tightly tied together. This (through Dr. Anfinsen's courtesy in 
letting us include his data) is shown schematically in two dimen­
sions in Fig. 10. One feature of the molecule is readily apparent 
from Figs. 9 and 10. Although the sequence around the 4-5 
disulfide link has not yet been completely worked out, there is 
no doubt that the small disulfide ring in this part of the molecul� 
is about equivalent in size to the one already found in insulin and 
also in the peptide hormones, vasopressin and oxytocin. 
As mentioned previously, the partial structural formula of 
ribonuclease (Fig. 8) is extremely useful as a guide in studies 
designed to learn more about the so-called "active center" of this 
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enzyme. The general problem of "active sites" is one of the most 
important in protein chemistry, because, of course, one of the 
main reasons for determining the structure of an enzyme is the 
hope that, in this manner, some insight will be gained into the 
basis for its catalytic properties. In research directed toward this 
end, Anfinsen34 has found that even minimal hydrolysis of ribo­
nuclease by pepsin abolishes enzymatic activity. Dr. F. M. 
Richards, now at Yale University, has observed that, after mild 
hydrolysis by the bacterial proteinase subtilisin, a new active peak 
appears upon chromatography of the hydrolyzate on columns of 
IRC-50.35 Dr. M. Uziel, in our laboratory, has been approaching 
the problem by studying the action of trypsin on ribonuclease in 
2 M guanidinium chloride. Ribonuclease is still active under these 
conditions, as Anfinsen36 found it to be in 8 Af urea, and attempts 
are now in progress to isolate active but altered products from such 
tryptic hydrolyzates. Since bonds at which trypsin may cleave the 
oxidized molecule are known (Fig. 8), the interpretation of the 
results of partial tryptic hydrolysis of "native" ribonuclease should 
be facilitated. 
This takes us as far as we can go at present in our structural 
analysis of ribonuclease. The completion of the task does not look 
as if it would present major difficulties, but it should be empha­
sized that one must always be on the lookout for surprises. Al­
though all that has been learned about ribonuclease so far is in 
accord with the working hypothesis that the molecule contains a 
single unbranched peptide chain, an experimenter must be pre­
pared to encounter unexpected linkages in proteins-linkages of 
the type that Craig and his colleagues encountered in bacitracin, 
for example. 
It is fair to ask, at this point, whether we have learned anything, 
in general, about the structure of proteins. We certainly do not yet 
know why ribonuclease is an enzyme. Moreover, examination of 
the structure of insulin, ACTH, glucagon, and ribonuclease has 
not yet revealed any common plan for the arrangement of the 
amino acid residues. Nor can we deduce anything about the 
nature of the metabolic machinery that synthesizes these proteins, 
except that it is amazingly precise and has not yet been found to 
make a mistake. A valine has never been found where a leucine 
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usually goes, for example. Each molecule of bovine ribonuclease 
appears to be like each other molecule, just as is the case for in­
sulin from a given species. 
Proteins are so complex in structure, so numerous, and ex­
hibit such diverse activities, that we cannot expect the many prob­
lems they raise to be solved by the incomplete information we now 
possess. Current knowledge of proteins is still relatively small; 
learning how to learn has been a major objective of the research 
thus far. It is hoped that the method of approach initiated by 
Sanger and expanded in the work on ribonuclease will also be gen­
erally applicab]e to larger and more complex molecules, for it is 
obviously going to be necessary to know the formulas of many 
proteins of different origins and different functions if we are to 
understand the many biochemical reactions in which proteins par­
ticipate. The approach that has been outlined in this lecture de­
pends heavily upon amino acid analysis, with particular emphasis 
upon the acquisition of quantitative data. The liberal use of amino 
acid analysis renders the approach quite general, since the same 
method of analysis is applicable to all proteins and peptides, no 
matter how different they may be. The quantitativeness of the 
procedures is important. When working with molecules as large 
and complex as the proteins, it is, in our experience, hard to over­
estimate the extent to which progress is expedited and error 
avoided by the availability of dependable quantitative data. 
It is obvious, however, that this scheme is only feasible if a 
relatively quick, simple, and accurate method of amino acid analy­
sis is at hand. In order to fulfill this need, automatic recording 
equipment has recently been devised with the skillful collabora­
tion of Dr. Spackman-equipment that permits a complete quanti­
tative analysis to be turned out every 24 hours with a minimum of 
labor. 37 This new technique has been of great value in the later 
phases of the work on ribonuclease, and it is hoped that it will 
catalyze further advances in our general knowledge of the struc­
ture of proteins. This, of course, is only one new development in 
a field that is expanding so rapidly that we feel sure that future 
Harvey Lecturers will be able to give us much more definitive 
information about Nature's most intricate molecular design-the 
proteins. 
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